About 43,075 results

ALLMedicine™ Migraine Center

Research & Reviews  11,865 results

Effectiveness, Safety and Predictors of Response to Ultrasound-Guided Stellate Ganglion...
Pain Practice : the Official Journal of World Institute O... Yu B, Zhang W et. al.

Mar 18th, 2023 - Whether ultrasound-guided stellate ganglion block (SGB) is a valuable therapeutic option for the treatment of patients with chronic migraine (CM) is worth exploring. If SGB is proven to be effective for CM, the identification of potential predicto...

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory...
The Journal of Headache and Pain; Ashina S, Melo-Carrillo A et. al.

Mar 18th, 2023 - The goal of this observational, open-label, cohort study was to determine whether prophylactic migraine treatment with galcanezumab, a peripherally acting drug, alters the incidence of premonitory symptoms, and/or occurrence of headache after expo...

Network pharmacology and experimental verification to explore the anti-migraine mechani...
Journal of Ethnopharmacology; Yu S, Chunlan F et. al.

Mar 17th, 2023 - Yufeng Ningxin Tablet (YNT) is a traditional Chinese medicine formula, that has been used clinically to treat migraine for many years. It is composed of one herb Pueraria lobata var. lobata (Willd.) Ohwi (Relevant Chinese name: Gegen). Previously,...

"Wearing-off" efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-an...
Cephalalgia : an International Journal of Headache; Asawavichienjinda T, Sathitratanacheewin S et. al.

Mar 17th, 2023 - A new migraine prevention, CGRP monoclonal antibodies (mAbs), is injectable on a monthly or quarterly basis. In clinical practice, some patients reported that drug effectiveness does not last until the upcoming scheduled injection, a so-called "we...

Real-world treatment satisfaction with erenumab in migraine: analysis of the US Nationa...
Current Medical Research and Opinion; Pathak P, Yue L et. al.

Mar 16th, 2023 - The treatment landscape for the prevention of migraine has rapidly evolved in recent years with the advent of calcitonin gene-related peptide therapy, including erenumab. The objective of this study was to assess patient-reported treatment satisfa...

see more →

Guidelines  17 results

ACR Appropriateness Criteria® Ataxia-Child.
Journal of the American College of Radiology : JACR; , Radhakrishnan R et. al.

Nov 28th, 2022 - Childhood ataxia may be due to multifactorial causes of impairment in the coordination of movement and balance. Acutely presenting ataxia in children may be due to infectious, inflammatory, toxic, ischemic, or traumatic etiology. Intermittent or e...

Guidelines of the International Headache Society for controlled trials of preventive tr...
Cephalalgia : an International Journal of Headache; Diener HC, Tassorelli C et. al.

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS...
Neuromodulation : Journal of the International Neuromodul... Leung A, Shirvalkar P et. al.

Mar 27th, 2020 - While transcranial magnetic stimulation (TMS) has been studied for the treatment of psychiatric disorders, emerging evidence supports its use for pain and headache by stimulating either motor cortex (M1) or dorsolateral prefrontal cortex (DLPFC). ...

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

see more →

Drugs  948 results see all →

Clinicaltrials.gov  1,408 results

Efficacy of Wet Cupping Therapy on Fibromyalgia

Mar 9th, 2023 - Background: Cupping therapy is a traditional treatment method especially belonging to our geography. In addition to being on the agenda as a traditional treatment method all over the world in recent years, it has also been the subject of an increa...

Comparison of Wet Cupping and Acupuncture in Migraine

Mar 9th, 2023 - Background: The most common primary headache is migraine. Migraine was ranked as the sixth cause of years lost due to disability all over the world in 2013. . About 15% of the world's population has migraine. Every year, 14-35% of women and 6-15% ...

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Mar 9th, 2023 - Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in chil...

Efficacy of Nerve Blocks for Episodic Migraine

Mar 9th, 2023 - Hypothesis: Multiple peripheral nerve blocks provide more complete acute headache relief and better headache prophylaxis in episodic migraine than greater occipital nerve blocks alone. Aims, purpose, or objectives: Compare whether anesthetizing mu...

A Study of Remote Electrical Neuromodulation for Acute Procedural Pain

Mar 9th, 2023 - The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation, using the Nerivio ® device, to relieve pain associated with receiving onabotulinumtoxinA (Botox) injections for chronic migraine prevention.

see more →

News  2,898 results

Evidence COVID Began in Raccoon Dog; Migraine Drug Recall; FDA Mum on Spring Booster

Mar 17th, 2023 - Note that some links may require subscriptions. A new analysis of genetic samples from China appears to link the origin of COVID-19 to raccoon dogs. (The Atlantic) What's a raccoon dog, anyhow? (Wikipedia) After a 2-year pandemic spike, maternal d...

Fast-Acting Nasal Spray for Migraine Snags FDA Approval

Mar 10th, 2023 - The FDA approved intranasal zavegepant (Zavzpret) for acute migraine, making it the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray with this indication, drugmaker Pfizer announced on Friday. Zavegepant is indicated fo...

Is self-administered DMPA an answer to contraception access in the post-Roe era?
MDedge Family Medicine; Lindsay Nakaishi, MD, MPH, DipABLM, Gregory Castelli, PharmD, FCCP, BCPS, BC-ADM, CDCES

Mar 9th, 2023 - ILLUSTRATIVE CASE A 32-year-old woman with a history of migraine with aura presents to your office for contraception management. She works full-time, has 2 children, and has transportation barriers.

Commentary: Pregnancy, photophobia, and stroke in relation to migraine, March 2023
Thomas Berk, MD

Mar 2nd, 2023 - Migraine is the single most common neurologic condition worldwide and is particularly predominant among women during their reproductive years. There are many important questions that arise when women with migraine start pregnancy planning, most of.

Visual hallucinations: Differentiating psychiatric and neurologic causes
James Dolbow, DO, Sean Duke, MD et. al.

Mar 1st, 2023 - A visual hallucination is a visual percept experienced when awake that is not elicited by an external stimulus. Historically, hallucinations have been synonymous with psychiatric disease, most notably schizophrenia; however, over recent decades, h.

see more →

Patient Education  94 results see all →